| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |